GPT and Coma: Five TEAEs were considered to be treatment related: 3 in the placebo group (increased blood creatine phosphokinase, bradycardia, and somnolence) and 1 in each namilumab group (150 mg: increased alanine aminotransferase; 300 mg: increased blood creatine phosphokinase).